• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

CYSTEAMINE Drug Record

  • Summary
  • Interactions
  • Claims
  • CYSTEAMINE chembl:CHEMBL602 Approved

    Alternate Names:

    MERCAPTAMINE
    L-1573
    MEA
    PROCYSBI
    CYSTEAMINE
    NSC-647528
    CYSTAGON
    BECAPTAN
    ETHANETHIOLAMINE
    MERCAMINE
    MERKAMIN
    Β-AMINOETHYLTHIOL
    2-AMINOETHANE-1-THIOL
    2-AMINOETHANETHIOL
    CISTEAMINA
    MECRAMINE
    2-AMINO-1-ETHANETHIOL
    BETA-AMINOETHYLTHIOL
    CASH
    LAMBRATENE
    CYSTEINAMINE
    2-AMINO-ETHANETHIOL
    LAMBRATEN
    DECARBOXYCYSTEINE
    Β-MEA
    B-AMINOETHANETHIOL
    BETA-AMINOETHANETHIOL
    CYSTEAMINE HYDROCHLORIDE
    B-AMINOETHYLTHIOL
    MERCAPTAMINA
    2-MERCAPTOETHANAMINE
    2-AMINOETHYL MERCAPTAN
    MERCAMIN
    (2-MERCAPTOETHYL)AMINE
    RIACON
    AMINOETHYL MERCAPTAN
    CYSTEAMIN
    BETA-MEA
    BETA-MERCAPTOETHYLAMINE
    MERCAPTAMIN
    MERCAPTAMINUM
    THIOETHANOLAMINE
    CI-9148
    CYSTEAMIDE
    B-MERCAPTOETHYLAMINE
    drugbank:00847
    chemidplus:60-23-1
    rxcui:3022
    chembl:CHEMBL602
    pubchem.compound:6058

    Drug Info:

    (0 More Sources)

    Publications:

    Tosco A et al., 2016, A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR., Cell Death Differ
    Ahrén et al., 1989, Cysteamine and the endocrine pancreas: immunocytochemical, immunochemical, and functional aspects., Cell Tissue Res.
    Terry et al., 1985, Cysteamine effects on monoamines, dopamine-beta-hydroxylase and the hypothalamic-pituitary axis., Neuroendocrinology
    McIntosh et al., 1988, Cysteamine-induced reduction in gastrointestinal somatostatin: evidence for a region-specific loss in immunoreactivity., Regul. Pept.
    Chen et al., 2002, TTD: Therapeutic Target Database., Nucleic Acids Res.
    McIntosh et al., 1984, Effect of cysteamine on secretion of gastrin and somatostatin from the rat stomach., Gastroenterology
  • CYSTEAMINE   SST

    Interaction Score: 17.67

    Interaction Types & Directionality:
    binder

    Interaction Info:

    PMIDs:
    2653642 4080089 2901134 11752352 6142843


    Sources:
    TTD

  • CYSTEAMINE   CFTR

    Interaction Score: 2.58

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    27035618


    Sources:
    PharmGKB

  • CYSTEAMINE   EHMT2

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • PharmGKB: cysteamine

    • Version: 18-August-2020

    Alternate Names:

    Drug Info:

    Publications:
    Tosco A et al., 2016, A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR., Cell Death Differ

  • TTD: Cysteamine

    • Version: 2020.06.01

    Alternate Names:
    D0V0LB TTD Drug ID

    Drug Info:

    Publications:

  • DTC: CYSTEAMINE

    • Version: 02-September-2020

    Alternate Names:
    CHEMBL602 ChEMBL Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL602

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21